COFCO Biotechnology Co., Ltd. (000930.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap10.69B
Enterprise Value10.6B
P/E Ratio-67.57
PEG Ratio0.62
Price/Sales Ratio0.53
Price/Book Ratio0.86
Enterprise/Revenue0.68
Enterprise/EBITDA490.79

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.01
Operating Margin-0.02
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.01

Income Statement

Revenue17.51B
Revenue/Share8.95
Gross Profit1.46B
EBITDA684.99M
Net Income38.37M
Diluted EPS0.02

Balance Sheet

Total Cash2.17B
Total Cash/Share1.17
Total Debt4.66B
Total Debt/Equity0.45
Current Ratio1.12
Book Value Per Share5.77

Price History

52-Week Change-22
52-Week High8.14
52-Week Low4.24
Moving Average 50 Days5.12
Moving Average 200 Days5.54

Statistics

Average Volume47.92M
Shares Outstanding1.86B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield0.63
Payout Ratio-1.12
Last Split Factor2:1
Last Split DateDecember 07, 2005
AD